cis-3-oxabicyclo[3.1.0]hexane-6-carboxylic acid
95%
- Product Code: 165310
CAS:
55685-58-0
Molecular Weight: | Molecular Formula: | ||
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used as a key intermediate in the synthesis of biologically active compounds, particularly in the development of pharmaceuticals targeting central nervous system disorders. Its rigid bicyclic structure and functional groups make it valuable for designing enzyme inhibitors and receptor modulators. Commonly employed in medicinal chemistry for structure-activity relationship studies due to its stereochemical stability and ability to mimic peptide bonds. Also utilized in the preparation of chiral building blocks for asymmetric synthesis.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿20,800.00 |
+
-
|
250mg | 10-20 days | ฿33,300.00 |
+
-
|
500mg | 10-20 days | ฿58,380.00 |
+
-
|
cis-3-oxabicyclo[3.1.0]hexane-6-carboxylic acid
Used as a key intermediate in the synthesis of biologically active compounds, particularly in the development of pharmaceuticals targeting central nervous system disorders. Its rigid bicyclic structure and functional groups make it valuable for designing enzyme inhibitors and receptor modulators. Commonly employed in medicinal chemistry for structure-activity relationship studies due to its stereochemical stability and ability to mimic peptide bonds. Also utilized in the preparation of chiral building blocks for asymmetric synthesis.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :